Test sensitivity in the European prostate cancer screening trial: results from Finland, Sweden, and the Netherlands.

Test sensitivity pertains to the ability of a test to identify subjects with the target disorder. In cancer screening, test sensitivity can be estimated using interval cancer incidence as an indicator of false-negative result. A randomized trial provides the optimal approach for estimating test sens...

Full description

Bibliographic Details
Main Authors: Auvinen, A, Raitanen, J, Moss, S, de Koning, H, Hugosson, J, Tammela, T, Roobol, M, Lilja, H, Hakama, M
Format: Journal article
Language:English
Published: 2009